Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Berkeley Antibody Company (AKA: BAbCO)
Profile last edited on: 1/9/15      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1983
First Award
1987
Latest Award
1995
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1223 South 47th Street
Richmond, CA 94804
   (510) 222-4940
   N/A
   www.babco.com
Location: Single
Congr. District: 11
County: Contra Costa

Public Profile

Berkeley Antibody Company provides custom antibody production, applied immunology, custom animal research, and preclinical evaluations. In November 1998, Berkeley Antibody was acquired by Covance Research Products (CRP) a firm which provides purpose-bred research animals and related services to the biomedical research community.

Extent of SBIR involvement

User Avatar
Phase I Awards
16
Phase II Awards
5
Conversion Rate
31.25%
Phase I Dollars
$765,000
Phase II Dollars
$2,273,037
Total Awarded
$3,038,037

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1995 2 NIH $800,000
Project Title: Antibody Specific for Human Homeobox Transcription FACB
1995 2 NIH $596,277
Project Title: Antibodies against PIT-1, TTF-1 and other DNA binging TR
1993 1 DOC $35,000
Project Title: An Immunoadsorbent Method for Segregating Fish Sperm Cells
1993 1 NIH $50,000
Project Title: Catalytic antibodies for chemiluminscence enhancement
1993 2 NIH $296,871
Project Title: Monoclonal antibodies/estrogen receptor isoforms

Key People / Management

  Thomas R Anderson -- President

  Krishna Balakrishnan

Company News

There are no news available.